Sucampo Pharmaceuticals, Inc. Stock

Stocks

27/12/17	Wall Street slips on tech sector weakness	RE
26/12/17	Mallinckrodt : to buy Sucampo for about $840 million	RE
09/11/16	Boeing : U.S. companies react cautiously to Trump victory	RE

03/01/18	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
29/12/17	SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc	BU
28/12/17	CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders	BU
28/12/17	SUCAMPO PHARMACEUTICALS, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
28/11/17	Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference	GL

27/12/17	Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
26/12/17	Apple : Les valeurs à suivre à Wall Street
08/12/17	Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
08/12/17	Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
19/04/17	Sucampo Pharmaceuticals : Veröffentlichung einer neuen Studie zu VTS-270 für die Behandlung von Morbus Niemann-Pick Typ C1 im Online-Fachjournal PLOS ONE Advances Science

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUCAMPO PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	+2.24%	+5.83%	+58.47%	+65.65%	66.7B
ARGENX SE	+4.66%	+8.90%	+14.57%	+85.41%	56.88B
LONZA GROUP AG	-0.60%	+1.73%	+23.48%	+94.40%	56.53B
BEONE MEDICINES AG	+2.66%	+15.53%	+26.78%	+120.19%	46.49B
IQVIA HOLDINGS INC.	+2.36%	+7.54%	+30.45%	+44.82%	44.8B
REVOLUTION MEDICINES, INC.	+2.92%	+5.31%	+215.89%	+889.81%	41.59B
CELLTRION, INC.	-0.47%	+9.60%	+27.53%	+52.88%	35.35B
GENMAB A/S	+3.80%	-1.00%	+95.20%	+66.79%	33.29B
INSMED INCORPORATED	+1.40%	+5.95%	-39.66%	+394.49%	25.1B
Average	+1.95%	+3.29%	+50.30%	+201.60%	45.19B
Weighted average by Cap.	+2.23%	+3.97%	+51.12%	+179.90%